Free Trial

Eton Pharmaceuticals (ETON) Earnings Date, Estimates & Call Transcripts

Eton Pharmaceuticals logo
$17.07 +0.28 (+1.66%)
As of 12:58 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Eton Pharmaceuticals Earnings Summary

Eton Pharmaceuticals issued Q4 2024 earnings on March 18, 2025, reporting an EPS of -$0.02, which met the consensus estimate of -$0.02. Quarterly revenue was reported to be $11.65 million, above analysts' expectations of $10.53 million. With a trailing EPS of -$0.15, Eton Pharmaceuticals' earnings are expected to grow next year, from ($0.14) to $0.50 per share.

Latest Q4
Earnings Date
Mar. 18Estimated
Consensus EPS
(Mar. 18)
-$0.02
Actual EPS
(Mar. 18)
-$0.02
Actual Revenue
(Mar. 18)
$11.65M

Q4 2024 Earnings Resources

Get Eton Pharmaceuticals Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Eton Pharmaceuticals and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

ETON Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

ETON Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Eton Pharmaceuticals Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20252$0.04$0.13$0.09
Q2 20252$0.06$0.08$0.07
Q3 20252$0.11$0.11$0.11
Q4 20252$0.18$0.33$0.26

Eton Pharmaceuticals Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
3/18/2025Q4 2024-$0.02-$0.02--$0.02$10.53M$11.65M
8/8/2024Q2 2024-$0.07-$0.12 -$0.05-$0.12$10.00M$9.07M
5/9/2024Q1 2024-$0.02-$0.03 -$0.01-$0.03$8.30M$7.97M
3/14/2024Q4 2023-$0.04-$0.09 -$0.05-$0.09$7.70M$7.31M
11/9/2023Q3 2023-$0.10-$0.02+$0.08-$0.02$6.30M$7.03M
8/10/2023Q2 2023-$0.09$0.18+$0.27$0.18$6.50M$12.00M

Eton Pharmaceuticals Earnings - Frequently Asked Questions

Eton Pharmaceuticals (NASDAQ:ETON) last announced its quarterly earning data on Tuesday, March 18, 2025. Learn more on ETON's earnings history.

In the previous quarter, Eton Pharmaceuticals (NASDAQ:ETON) reported ($0.02) earnings per share (EPS) to hit the analysts' consensus estimate of ($0.02). Learn more on analysts' earnings estimate vs. ETON's actual earnings.

Eton Pharmaceuticals (NASDAQ:ETON) has a recorded annual revenue of $39.01 million.

Eton Pharmaceuticals (NASDAQ:ETON) has a recorded net income of -$940,000.00. ETON has generated -$0.15 earnings per share over the last four quarters.

Eton Pharmaceuticals's earnings are expected to grow from ($0.14) per share to $0.50 per share in the next year.

More Earnings Resources from MarketBeat



This page (NASDAQ:ETON) was last updated on 5/12/2025 by MarketBeat.com Staff
From Our Partners